Allarity Therapeutics (ALLR) Q4 2025 Earnings

14NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-8.4
-5.65
-2.9
-0.15

Details

Expected EPS
-0.23
Actual EPS
-0.19
Surprise EPS
0.04
Surprise Percent
+17.39%

Description

Allarity Therapeutics (ALLR) has reported earnings of -0.19 per share for Q4 2025.

0 Comments

Share your thoughts